Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

December 28, 2022

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

News Daily News

COAPT Risk Score Useful in Predicting Outcomes in Functional MR

Michael O'Riordan

October 05, 2022

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

August 11, 2022

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

News Daily News

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

March 16, 2022

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

March 08, 2022

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.